Status of surfactants as penetration enhancers in transdermal drug delivery

Journal of Pharmacy and Bioallied Sciences

Volumn 4, Issue 1, 2012, Pages 2-9

  Som, Iti ^a   Bhatia, Kashish ^a   Yasir, Mohd ^a  

^a ITS Paramedical College (Pharmacy)   (India)

Author keywords

Penetration enhancer; skin; sodium lauryl sulfate; surfactant; Tween 80

Indexed keywords

ANIONIC SURFACTANT; BENZALKONIUM CHLORIDE; BENZOCAINE; CATIONIC SURFACTANT; CETRIMIDE; CETYLPYRIDINIUM SALT; DIAZEPAM; DIETHYLENE GLYCOL MONOETHYL ETHER; DODECYL SULFATE SODIUM; FOSCARNET; HALOPERIDOL; IBUPROFEN; IONIC SURFACTANT; KETOTIFEN; LORAZEPAM; NALOXONE; NICOTINIC ACID METHYL ESTER; NONOXINOL; POLOXAMER; POLYOXYETHYLENE ALKYL ETHER; POLYSORBATE 20; POLYSORBATE 60; POLYSORBATE 80; PROPOFOL; SORBITAN LAURATE; SORBITAN OLEATE; SORBITAN PALMITATE; SORBITAN TRIOLEATE; SURFACTANT; UNINDEXED DRUG;

CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; DRUG DELIVERY SYSTEM; DRUG PENETRATION; HYDROPHILICITY; HYDROPHOBICITY; LIPOPHILICITY; MEMBRANE PERMEABILITY; MOLECULAR WEIGHT; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; REVIEW; SOLUBILITY; STRATUM CORNEUM; TRANSDERMAL DRUG ADMINISTRATION;

EID: 84856813200     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.92724     Document Type: Review

References (60)

1. Kumar R, Philip A. Modified Transdermal Technologies: Breaking the barriers of drug permeation via the skin. Tropical J Pharm Res. 2007;6:633-44.
2. Williams AC, Barry BW. Penetration enhancers. Adv Drug Del Rev. 2004;56:603-18. (Pubitemid 38326936)
3. Barry BW. Mode of action of penetration enhancers in human skin. J Control Release 1987;6:85-97. (Pubitemid 18017724)
4. Piret J, Désormeaux A, Cormier H, Lamontagne J, Gourde P, Juhász J, et al. Sodium lauryl sulfate increases the efficacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice. Antimicrob Agents Chemother.2000;44:2263-70. (Pubitemid 30650866)
5. Tadros TF. Applied surfactants: Principles and applications. KGaA:Weinheim: Wiley-VcH Verlag GmbH &Co. 2005.p.437.
6. Malmsten M. Surfactants and Polymers in drug delivery. Sweden: Marcel dekker;2002.
7. Smith EW, Maibach HI. Percutaneous penetration enhancer. 2 nd ed. Boca Raton:Taylor and Francis;2005.
8. Somasundaran P, Hubbard A. Encyclopedia of Surface and Colloid Science. Pezron I. 2 nd ed. New York: Taylor and Francis;2006.
9. Allen LV, Popovich NG, Ansel HC. Pharmaceutical dosage forms and drug delivery systems. 8 th ed. Baltimore:Lippincott Williams &Wilkins;2005.
10. Barel AO, Paye M, Maibach HI. Handbook of cosmetic science and technology. 3 rd ed. New York:Marcel Dekker;2009.
11. Ananthapadmanabhan KP, Yu KK, Meyers CL, Aronson MP. Binding of surfactants to Stratum Corneum. J Soc Cosmet Chem 1996;47:185-200.
12. Rhein LD, Robbins CR, Fernee K, Cantore R. Surfactant structure effects on swelling of isolated human stratum corneum. J Soc Cosmet Chem 1986;37:125-39.
13. Gloxhuber C, Kunstler K. Anionic surfactants: Biochemistry, toxicology, dermatology. Surfactant science series. 2 nd ed. New York:Marcel Dekker;1992.
14. Fulmer AW, Kramer GJ. Stratum corneum lipid abnormalities in surfactant induced dry scaly skin. J Invest Dermatol 1986;86:598-02.
15. Jantharaprapap R, Stagni G. Effects of penetration enhancers on in vitro permeability of meloxicam gels. Int J Pharm 2007;343:26-33. (Pubitemid 47321008)
16. Patil S, Singh P, Maibach H. Radial spread of sodium lauryl sulfate after topical application. Pharm Res 1995;12:2018-23. (Pubitemid 26031790)
17. Huang CM, Wang CC, Kawai M, Barnes S, Elmets CA. Surfactant sodium lauryl sulfate enhance skin vaccination. http://www.mcponline.org/content/5/3/523. full. (Accessed November 28, 2005).
18. Walters KA, Bialik W, Brain KR. The effects of surfactants on penetration across the skin. Int J Cosmet Sci 1993;15:260-70. (Pubitemid 24019236)
19. Walters KA, Walker M, Olejnik O. Non-ionic surfactant effects on hairless mouse skin permeability characteristics. J Pharm Pharmacol 1988;40:525-29.
20. Kitagawa S, Kasamaki M, Hiyama F. Effects of double-chained cationic surfactants n-dimethyldialkylammoniums on skin permeation of benzoic acid through excised guinea pig dorsal skin: comparison of their enhancement effects with hemolytic effects on erythrocytes. Chem Pharm Bull 2001;49:1155-58. (Pubitemid 32847523)
21. Park ES, Chang SY, Hahn M, Chi SC. Enhancing effect of polyoxyethylene alkyl ethers on the skin permeation of ibuprofen. Int J Pharm. 2000;209:109-19.
22. Okuyama H Ikeda Y, Kasai S, Imamori K, Takayama K. Nagai T. Influence of non-ionic surfactants, pH and propylene glycol on percutaneous absorption of piroxicam from cataplasm. Int J Pharm. 1999;186:141-48. (Pubitemid 29459041)
23. Dalvi UG, Zatz J. Effects of nonionic surfactants on penetration of dissolved benzocaine through hairless mouse skin. J Soc Cosmet Chem1999;32:87-94.
24. Kushla GP, Zatz JL. Correlation of water and lidocaine flux enhancement by cationic surfactants in vitro. J Pharm Sci 1991;80:1079-83.
25. Lopez A, Llinares F, Cortell C, Herraez M. Comparative enhancer effects of Span®20 with Tween®20 and Azone®on the in vitro percutaneous penetration of compounds with different lipophilicities. Int J Pharm 2000;202:133-40. (Pubitemid 30466239)
26. Froebe CL, Simion FA, Rhein LD, Cagan RH, Kligman A. Stratum corneum lipid removal by surfactants: Relation to in vivo irritation. Dermatologica 1990;181:277-83.
27. Aulton ME. Pharmaceutics-The science of dosage form design, 2 nd ed. Philadelphia (US): Churchill Livingstone;2002.
28. Swarbrick J. Encyclopedia of pharmaceutical technology. Surfactants in pharmaceutical products and systems. 3 rd ed. Vol 6. Informa Healthcare,CRC press hardcover;2006.
29. Reiger MM, Rhein LD. Surfactant in Cosmetics, Vol 68 New York:Marcel Dekker;1997.
30. Lee CK, Uchida T, Kitagawa k, Yagi K, Kim NS, Goto S. Skin permeability of various drugs with different lipophilicity. J Pharm Sci 1994;83:562-65. (Pubitemid 24222384)
31. Scheuplein RJ, Ross L. Effects of surfactants and solvents on the permeability of epidermis. J Soc Cosmet Chem 1970;21:853-73.
32. Walker RB, Smith EW. The role of percutaneous penetration enhancer. Adv Drug Del Rev 1996;18:295-01.
33. Nokhodchi A, Shokri J, Dashbolaghi A, Hassan-zadeh D, Ghafourian T, Barzegar-jalali M. The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int J Pharm 2003;250:359-69. (Pubitemid 36084360)
34. Cappel MJ, Kreut J. Effect of nonionic surfactants on transdermal drug delivery: I. Polysorbates. Int J Pharm. 1991;69:143-53.
35. Shokri J, Nokhodchi A, Hassan-zadeh D, Ghafourian T, Barzegar-jalali M. The effect of surfactants on the skin penetration of diazepam. Int J Pharm 2001;228:099-107.
36. Shen WW, Danti AG, Bruscato FN. Effect of nonionic surfactants on percutaneous absorption of salicylic acid and sodium salicylate in the presence of dimethyl sulfoxide. J Pharm Sci 1976;65:1780-83. (Pubitemid 8001791)
37. Hwang CC. Percutaneous absorption of flufenamic acid in rabbits: effect of dimethyl sulfoxide and various nonionic surface-active agents. J Pharm Sci 1983;72:857-60. (Pubitemid 13040636)
38. Walters KA, Hadgraft. J. Pharmaceutical skin penetration enhancement, Vol 59 New York: Marcel Dekker;1993.
39. Ridout G, Hostynek JJ, Reddy AK, Wiersema RJ, Hodson CD. Lorence CR, et al. The effects of zwitterionic surfactants on skin barrier function. Fundamental and applied toxicology 1991;16:41-50.
40. Kitagawa S. Enhanced skin permeation of cationic drug ketotifen through excised guinea pig dorsal skin by surfactants with different electric charges. Chem Pharm Bull 2003;51:1183-85. (Pubitemid 41663078)
41. Keisuke Y, Yuri T, Hidero A, Kazuyuki T, Hiraku O, Yoshiharu, M. Effect of penetration enhancer on transdermal delivery of propofol, Biol Pharm Bull 2009;32:677-83.
42. Aungst BJ, Rogers NJ, Shefter E. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulphoxides and amides. Int J Pharm 1986;33:225-34. (Pubitemid 17197807)
43. Vaddi HK, Wang LZ, Ho PC, Chan SY. Effect of some enhancer on the permeation of haloperidol through rat skin in vitro. Int J Pharm 2001;212:247-55. (Pubitemid 32119450)
44. Zhao H, Choi MK, Kim JS, Yong CS, Choi HG, Chung SJ, et al. Synergistic enhancing effect of DEET and dodecylamine on the skin permeation of testosterone from a matrix type transdermal delivery system. Drug Deliv 2009;16:249-53.
45. Fang JY, Fang CL, Huang YB, Tsai YH, Transdermal iontophoresis of sodium nonivamide acetate.III combined effect of pretreatment by penetration enhancer. Int J Pharm 1997:149:183-93.
46. Ashton P, Walters KA, Brain, KR, Hadgraft J. Surfactant effects in percutaneous absorption effects on the transdermal flux of methyl nicotinate. Int J Pharm 1992;87:261-64.
47. Endo M, Yamamoto T, ljuin T. Effect of nonionic surfactants on the percutaneous absorption Tenoxicam. Chem Pharm Bull 1996;44: 865-67. (Pubitemid 26146973)
48. Mukherjee B, Priya K, Mahapatra S, Das S, Sorbitan monolaurate 20 as a potential skin permeation enhancer in transdermal patches. J App Res 2005;5:96-98.
49. Shin SC, Cho CW, Oh I.J. Effects of non-ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins. Int J Pharm 2001;222:199-203.
50. Shin SC, Lee HJ. Enhanced transdermal delivery of triprolidine from the ethylene-vinyl acetate matrix. Eur J Pharm Biopharm 2002;54:325-28.
51. Sarpotdar PP, Zatz JL, Evaluation of penetration enhancement of lidocaine by nonionic surfactants through hairless mouse skin in vitro. J Pharm Sci 1986;75:176-81. (Pubitemid 16162543)
52. Limpongsa E, Umprayn K. Preparation and evaluation of diltiazem hydrochloride diffusion controlled transdermal drug delivery. AAPS Pharm Sci Tech 2008;9:464-70.
53. Kumar D, Aqil M, Rizwan M, Sultana Y, Ali M. Investigation of a nanoemulsion as vehicle for transdermal delivery of Amlodipine. Pharmazie 2009;64:80-85.
54. Park ES, Chang SY, Hahn M, Chi SC. Enhancing effect of polyoxyethylene alkyl ethers on the skin permeation of ibuprofen. Int J Pharm 2000;209:109-19.
55. Sarpotdar PP, Zatz JL. Percutaneous Absorption Enhancement by Nonionic Surfactants. Drug Dev Ind Pharm 1987;13:15-37. (Pubitemid 17017611)
56. Arellano A, Santoyo S, Martn C, Ygartua P. Surfactant effects on the in vitro percutaneous absorption of diclofenac sodium. Eur J Drug Metab Pharmacokinet 1998;23:307-12. (Pubitemid 28401124)
57. Bhaskaran S, Harsha SN. Effect of permeation enhancer and iontophoresis on permeation of atenolol from transdermal gels. Ind J Pharm Sci 2000;62:424-26. (Pubitemid 32422257)
58. Shen WW, Danti AG, Bruscato FN. Effect of nonionic surfactants on percutaneous absorption of salicylic acid and sodium salicylate in the presence of dimethyl sulfoxide. J Pharm Sci 976;65:1780-83.
59. U.S. Food and Drug Administration, Title 21, Code of Federal Regulations, Part 182, 184, 186. Office of the Federal Register, National Archives and Records Administration 2007.
60. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Guidance for Industry: Nonclinical studies for the safety evaluation of pharmaceutical excipients,Office of Training and Communication, Division of Drug Information, HFD-240, Center for Drug Evaluation and Research, Food and Drug Administration, or Office of Communication, Training, and Manufacturers Assistance, HFM-40,Center for Biologics Evaluation and Research,Food and Drug Administration. May 2005. http://www.fda.gov/cder/ guidance/5544fnl.pdf